CHMP approves 5 new drugs in March

Five new treatments have received a positive opinion at the CHMP’s monthly meeting in March, while six new indication extensions have been recommended.

Photo: Piroschka Van De Wouw/Reuters/Ritzau Scanpix

A total sum of 25 drugs have been recommended for European use three months into 2022.

The European Medicines Agency’s (EMA) expert committee, the CHMP, has concluded its March meeting, results of which brought the year’s total of new drug recommendations up by five. The drugs have therefore made it one step closer to the official approval, which is granted by the EU Commission.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs